In Vitro Diagnostics Market Research Reports & Industry Analysis

The publications below represent comprehensive market research on components of the global market for in vitro diagnostics. Reports, published by several different research companies, address financial analyses of major companies, overview analyses of the global market, and specific analyses on individual countries or individual and more specific segments of the market, such as cell analysis.
...Show More ...Show Less


In Vitro Diagnostics Industry Research & Market Reports

  • Flow Chemistry

    ... CAGR of 8.8% over the analysis period 2024-2030. CSTR, one of the segments analyzed in the report, is expected to record a 8.9% CAGR and reach US$1.1 Billion by the end of the analysis period. ... Read More

  • Cell Proliferation Kits

    ... at a CAGR of 5.5% over the analysis period 2024-2030. Pharma & Biotech Companies End-Use, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$394.2 Million by ... Read More

  • C-Reactive Protein Testing

    ... at a CAGR of 1.7% over the analysis period 2024-2030. Cardiovascular Diseases, one of the segments analyzed in the report, is expected to record a 2.6% CAGR and reach US$1.0 Billion by the end of ... Read More

  • Endocrine Testing

    ... CAGR of 5.0% over the analysis period 2024-2030. Thyroid Stimulating Hormone (TSH) Testing, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$6.3 Billion by the end ... Read More

  • Coagulation Testing

    ... CAGR of 4.8% over the analysis period 2024-2030. Coagulation Testing Consumables, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$3.7 Billion by the end of the ... Read More

  • Aptamers

    ... 15.7% over the analysis period 2024-2030. DNA Aptamers, one of the segments analyzed in the report, is expected to record a 15.7% CAGR and reach US$227.5 Million by the end of the analysis period. Growth ... Read More

  • Automated Liquid Handling Systems

    ... 2030, growing at a CAGR of 10.8% over the analysis period 2024-2030. Automated Liquid Handling Workstations, one of the segments analyzed in the report, is expected to record a 11.6% CAGR and reach US$1.6 Billion ... Read More

  • Urinalysis

    ... 5.0% over the analysis period 2024-2030. Urinalysis Consumables, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$4.1 Billion by the end of the analysis period. Growth ... Read More

  • Veterinary Diagnostics

    ... CAGR of 7.0% over the analysis period 2024-2030. Veterinary Diagnostic Consumables, one of the segments analyzed in the report, is expected to record a 8.1% CAGR and reach US$2.6 Billion by the end of the ... Read More

  • Zika Virus Testing

    ... at a CAGR of 5.8% over the analysis period 2024-2030. Molecular Testing, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$192.4 Million by the end of ... Read More

  • D-dimer Testing

    ... CAGR of 4.0% over the analysis period 2024-2030. D-dimer Testing Reagents & Consumables, one of the segments analyzed in the report, is expected to record a 3.6% CAGR and reach US$1.3 Billion by the end ... Read More

  • Rapid Medical Diagnostic Kits

    ... 2030, growing at a CAGR of 3.6% over the analysis period 2024-2030. Over the Counter (OTC) Kits, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$10.7 ... Read More

  • Hemostasis Diagnostics

    ... CAGR of 4.8% over the analysis period 2024-2030. Prothrombin Test Time (PT), one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach US$1.3 Billion by the end of ... Read More

  • Coagulation Factor Concentrates

    ... at a CAGR of 7.2% over the analysis period 2024-2030. Hospitals & Clinics End-Use, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$8.8 Billion by the ... Read More

  • In Vitro Diagnostics (IVD) Quality Control

    ... reach US$1.8 Billion by 2030, growing at a CAGR of 5.3% over the analysis period 2024-2030. Clinical Chemistry Application, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and ... Read More

  • Molecular Quality Controls

    ... at a CAGR of 5.0% over the analysis period 2024-2030. Independent Controls, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$211.3 Million by the end of ... Read More

  • Atomic Spectroscopy

    ... CAGR of 6.9% over the analysis period 2024-2030. Pharmaceuticals & Biotechnology Testing Application, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$6.2 Billion by the end ... Read More

  • ATP Assay

    ... CAGR of 7.1% over the analysis period 2024-2030. ATP Assay Consumables & Accessories, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$487.0 Million by the end ... Read More

  • Microtomes

    ... 6.0% over the analysis period 2024-2030. Microtome Instruments, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$162.8 Million by the end of the analysis period. Growth ... Read More

  • Patient Blood Management

    ... at a CAGR of 6.5% over the analysis period 2024-2030. Patient Blood Management Instruments, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$10.1 Billion by the ... Read More

  • Preimplantation Genetic Testing

    ... at a CAGR of 10.1% over the analysis period 2024-2030. Preimplantation Genetic Testing Reagents & Consumables, one of the segments analyzed in the report, is expected to record a 10.8% CAGR and reach US$794.1 Million ... Read More

  • Rapid Microbiology Testing

    ... at a CAGR of 7.5% over the analysis period 2024-2030. Rapid Microbiology Testing Instruments, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach US$4.9 Billion by the ... Read More

  • Prenatal Diagnostics

    ... CAGR of 12.8% over the analysis period 2024-2030. Non-Invasive Test, one of the segments analyzed in the report, is expected to record a 15.3% CAGR and reach US$10.6 Billion by the end of the analysis ... Read More

  • Hematology Instruments and Reagents

    ... 2030, growing at a CAGR of 4.3% over the analysis period 2024-2030. Hematology Analyzers, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$4.3 Billion by the ... Read More

  • High Content Screening (HCS)

    ... 2030, growing at a CAGR of 9.2% over the analysis period 2024-2030. HCS Instruments, one of the segments analyzed in the report, is expected to record a 9.4% CAGR and reach US$1.0 Billion by the ... Read More

Cookie Settings